1avtoportal.ru


Масло не желчегонное
9 372

    Восстановление после операции радикальная простатэктомия

    Раздел: Гипертония Дата публикации: 23.05.2015, 15:04

    1. Велиев Е.И., Ванин А.Ф., Котов С.В., Шишло В.К. Современные аспекты патофизиологии и профилактики эректильной дисфункции и кавернозного фиброза после радикальной простатэктомии. Урология. -2009. №2 - стр. 46-51.

    2. Гамидов С.И. Особенности патогенеза и диагностики эректильной дисфункции у пациентов перенесших тупую травму промежности и радикальные операции на тазовых органах. Дисс. канд.мед.наук. Москва, 1998

    3. Говоров А.В., Пушкарь Д.Ю., Максимов В.А., Давыдова Е.Н. Эпидемиология рака предстательной железы в России в 1997 — 2007 гг. Материалы V конгресса Российского общества онкоурологов. Москва 6-8 октября 2010 г. С.51- 52.

    4. Камалов А. А., Хомерики Г. Г., Ефремов Е. А., Ромих В. В., Егоров А. А., Охоботов Д. А. Качество жизни больных после радикальной простатэктомии . Урология 2005.-N 4.-С.27-29

    5. Камалов А.А., С.Д.Дорофеев, Е.А.Ефремов. Современная медикаментозная терапия эректильной дисфункции CONSILIUM MEDICUM Том 08/N 4/2006

    6. Котов С.В. Профилактика кавернозного фиброза после нервосберегающей радикальной простатэктомии: диссертация на соискание ученой степени кандидата медицинских наук. РМАПО 2009 г. 105 с.

    7. Лоран О.Б., Е.И. Велиев, В.А. Няхин. Анализ качества жизни пациентов в течение первого года после радикальной позадилонной простатэктомии. // Журнал Онкоурология М., 2005. — №2. — С. 50 -53.

    8. Лоран О.Б., Сегал А.С. шкала количественной оценки мужской копулятивной функции (шкала МКФ).//Урология и нефрология 1998-№5-С. 24-27.

    9. Мазо Е. Б. , Гамидов С. И., Иремашвили В. В., Сотникова Е. М., Гасанов Р. В. Эффективность ингибиторов фосфодиэстеразы в лечении больных органической эректильной дисфункцией: сравнительное исследование Урология №1 2009

    10. Мазо Е.Б., Гамидов С.И., Овчинников Р.И., Иремашвили В.В .Новые аспекты патогенеза, профилактики и лечения эректильной дисфункции у больных после радикальной простатэктомии CONSILIUM MEDICUM 2004 ТОМ 6 №7

    11. Мазо Е.Б., С.И.Гамидов, Р.И.Овчинников, Р.В.Гасанов, Д.В.ЩербаковВлияние длительного приема варденафила на эректильную и эндотелиальную функцию у больных с артериогеннойэректильной дисфункцией Терапевтический архив 2009.-N 10.-С.70-73.

    12. Нишлаг Э , Бере М. Андрология. Мужское здоровье и дисфункция репродуктивной системы: пер. с англ. под ред. И. И. Дедова. М.: Мед. информ. агентство; 2005.

    13. Няхин В. А. Функциональные результаты и качество жизни пациентов после радикальной позадилонной простатэктомии диссертация на соискание ученой степени кандидата медицинских наук. РМАПО 2007 г. 182 с.

    14. Пушкарь Д. Ю., Раснер П. И. Диагностика и лечение локализованного рака предстательной железы. М.: МЕДпресс-информ; 2008.

    15. Пушкарь Д.Ю., Бормотин А. В., Говоров A.B. Лечение эректильной дисфункции у пациентов, перенесших радикальную позадилонную простатэктомию, с использованием ингибиторов фосфодиэстеразы типа 5 III Качество жизни. Медицина. — 2007. —N5 . — С. 36-41.

    16. Пушкарь, Д. Ю. В. В. Дьяков, А. Н. Берников Качество жизни -новая парадигма медицины / // Фарматека : международный медицинский журнал. — 2005. —N 11 . — С. 15-16.

    17. Ракул С.А.,С.Б. Петров, М.Д. Иванова, H.H. петрова Апробация «Универсального опросника качества жизни больных раком предстательной железы» // Онкоурология : ежеквартальный научно-практический журнал. — 2009. — N 2 . — С. 64-73.

    18. Роюк Р. В. Оптимизация методов диагностики и коррекции осложнений радикальной простатэктомии диссертация на соисканиеученой степени кандидата медицинских наук. РУДН-2007 г.

    19. Ситников Н. В. Профилактика осложнений и ранняя реабилитация больных после радикальной простатэктомии диссертация на соискание ученой степени доктора медицинских наук. ФГУ 3 ЦВКГ 2008 г.

    20. Щеплев П.А., Аполихин О.И. Андрология. Клинические рекомендации: Москва: Медпрактика-М, 2007.-164 с.

    21. Agarwal PK, Oefelein MG. Testosterone replacement therapy after primary treatment for prostate cancer. J Urol. 2005 Feb;173(2):533-6.

    22. Ahlering ТЕ, Kaplan AG, Yee DS, Skarecky DW. Prostate weight and early potency in robot-assisted radical prostatectomy. Urology. 2008 Dec;72(6): 1263-8. Epub 2008 Aug 13.

    23. Ahlering ТЕ, Skarecky D, Borin J. Impact of cautery versus cautery-free preservation of neurovascular bundles on early return of potency. J Endourol. 2006; 20: 586.

    24. Akbal C, Türker P, Tavukgu HH, Sim§ek F, Türkeri L. Erectile function in prostate cancer-free patients who underwent prostate saturation biopsy. Eur Urol. 2008 Mar;53(3):540-4. Epub 2007 Jul 2.

    25. Allaf ME, Hoke A, Burnett AL. Erythropoietin promotes the recovery of erectile function following cavernous nerve injury. J Urol. 2005 Nov; 174(5) :2060-4

    26. Altwein J, Ekman P, Barry M, et al: How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology. 1997;49: 66-76.

    27. Anastasiadis AG, Salomon L, Katz R, Hoznek A, Chopin D, Abbou CC: Radical retropubic versus laparoscopic prostatectomy: a prospective comparison of functional outcome. Urology 2003; 62: 292.

    28. Audouin M, Beley S, Cour F, Vaessen C, Chartier-Kastler E, Bitker MO, Richard F, Roupret M. Erectile dysfunction after radical prostatectomy: pathophysiology, evaluation and treatment. Prog Urol. 2010 Mar;20(3):172-82. Epub 2009 Jul 21. Abstract

    29. Bannowsky A, Schulze H, van der Horst C, Hautmann S, Junemann KP. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int 2008; 101:1279-83.

    30. Barnas J, Parker M, Guhring P, Mulhall JP. The utility of tamsulosin in the management of orgasm-associated pain: a pilot analysis. Eur Urol. 2005 Mar;47(3):361-5; discussion 365.

    31. Barnas JL, Pierpaoli S, Ladd P, Valenzuela R, Aviv N, Parker M, Waters WB, Flanigan RC, Mulhall JP. The prevalence and nature of orgasmic dysfunction after radical prostatectomy. BJU Int. 2004 Sep;94(4):603-5.

    32. Bechara A, Casabe A, Cheliz G, et al. Prostaglandin El versus mixture of prostaglandin El, papaverine and phentolamine in non-responders to high papaverine plus phentolamine doses. J Urol 1996;155:913-4.

    33. Bechara A, Casabe A, Cheliz G, Romano S, Rey H, Fredotovich N. Comparative study of papaverine plus phentolamine versus prostaglandin El in erectile dysfunction. J Urol. 1997 Jun;157(6):2132-4.

    34. Bella AJ, Fandel TM, Tantiwongse K, Brant WO, Klein RD, Garcia CA, Lue TF. Neurturin enhances the recovery of erectile function following bilateralcavernous nerve crush injury in the rat. J Brachial Plex Peripher Nerve Inj. 2007 Mar 6;2:5.

    35. Bella AJ, Hayashi N, Carrion RE, Price R, Lue TF. FK1706 enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat. J Sex Med. 2007 Mar;4(2):341-6; discussion 346-7.

    36. Bella AJ, Lin G, Cagiannos I, Lue TF. Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury. Asian J Androl. 2008 Jan;10(l):54-9.

    37. Benoit G, Droupy S, Quillard J, Paradis V and Giuliano F: Supra and infralevator neurovascular pathways to the penile corpora cavernosa. J Anat 1999; 195: 605.

    38. Benoit RM, Naslund MJ, Cohen JK: Complications after radical retropubic prostatectomy in the medicare population. Urology 2000; 56: 116.

    39. Bochinski D, Lin GT, Nunes L, Carrion R, Rahman N, Lin CS, Lue TF. The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int. 2004 Oct;94(6):904-9.

    40. Bosshardt RJ, Farwerk R, Sikora R, et al. Objective measurement of the effectiveness, therapeutic success and dynamic mechanisms of the vacuum device. Br J Urol. 1995 Jun;75(6):786-91.

    41. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 2005 Mar;16(3):481-8. Epub 2005 Feb 17.

    42. Braslis KG, Santa-Cruz C, Brickman AL, Soloway MS.Quality of life 12 months after radical prostatectomy. Br J Urol. 1995 Jan;75(l):48-53.

    43. Bratton RL, Cassidy HD. Vacuum erection device use in elderly men: a possible severe complication. J Am Board Fam Pract. 2002 Nov1. Dec;15(6):501-2.

    44. Breza J, Aboseif SR, Orvis BR, Lue TF and Tanagho EA: Detailed anatomy of penile neurovascular structures: surgical significance. J Urol 1989; 141: 437.

    45. Brock G, Nehra A, Lipshultz LI, et al. Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol 2003;170:1278-83.

    46. Brock G, Tu LM, Linet OI. Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment. Urology 2001;57:536-41.

    47. Burnett AL, Becker RE. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury. J Urol. 2004 Jan;171(l):495-500.

    48. Burnett AL, Teloken PE, Briganti A, Whitehurst T, Montorsi F. Intraoperative assessment of an implantable electrode array for cavernous nerve stimulation. J Sex Med. 2008 Aug;5(8): 1949-54. Epub 2008 May 5.

    49. Carrier S, Zvara P, Nunes L, Kour NW, Rehman J, Lue TF. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J Urol 1995; 153: 1722-7.

    50. Catania JA, Binson D, Canchola J, Pollack LM, Hauck W, Coates TJ: Effects of interviewer gender, interviewer choice, and item wording on responses to questions concerning sexual behavior. Public Opin Q 1996; 60: 345

    51. Chang CM, Moon D, Gianduzzo TR, et al. The impact of prostate size in laparoscopic radical prostatectomy. Eur Urol. 2005;48:285-290.

    52. Chen KC, Minor TX, Rahman NU, Ho HC, Nunes L, Lue TF. The additive erectile recovery effect of brain-derived neurotrophic factor combined withvascular endothelial growth factor in a rat model of neurogenic impotence. BJU Int. 2005 May;95(7): 1077-80.

    53. Chien GW, Mikhail AA, Orvieto MA, Zagaja GP, Sokoloff MH, Brendler CB et al: Modified clipless antegrade nerve preservation in robotic-assisted laparoscopic radical prostatectomy with validated sexual function evaluation. Urology 2005; 66: 419.

    54. Choi JM, Nelson CJ, Stasi J, Mulhall JP. Orgasm associated incontinence (climacturia) following radical pelvic surgery: rates of occurrence and predictors. J Urol. 2007 Jun;177(6):2223-6.

    55. Chrisofos M, Papatsoris AG, Dellis A, Varkarakis IM, Skolarikos A, Deliveliotis C. Can prostate biopsies affect erectile function? Andrologia 2006;38:79-83.

    56. Costello AJ, Brooks M, Cole OJ. Anatomical studies of the neurovascular bundle and cavernosal nerves. BJU Int 2004;94:1071-6.

    57. Dalkin BL, Christopher BA, Shawler D: Health related quality of life outcomes after radical prostatectomy:attention to study design and the patient-based importance of single-surgeon studies. Urol Oncol 2006; 24: 28

    58. Dalkin BL, Christopher BA. Preservation of penile length after radical prostatectomy: early intervention with a vacuum erection device. Int J Impot Res. 2007 Sep-Oct;19(5):501-4. Epub 2007 Jul 26.

    59. Davison BJ, So AI, Goldenberg SL. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer. BJU Int. 2007 Oct; 100(4):780-5. Epub 2007 Jun 19.

    60. De Luca V, Pescatori ES, Taher B, Zambolin T, Giambroni L, Frego E, et al. Damage to the erectile function following radical pelvic surgery: prevalence of veno-occlusive dysfunction. Eur Urol 1996;29:36-40.

    61. Dorey G, Speakman MJ, Feneley RC, Swinkels A, Dunn CD. Pelvic floor exercises for erectile dysfunction. BJU Int. 2005 Sep;96(4):595-7.

    62. Dubbelman Y, Wildhagen M, Schroder F, Bangma C, Dohle G. Orgasmic

    63. Dysfunction After Open Radical Prostatectomy: Clinical Correlates and Prognostic Factors J Sex Med. 2009 Nov 13. Epub ahead of print.

    64. Eichelberg C, Erbersdobler A, Michl U, et al. Nerve distribution along the prostatic capsule. Eur Urol 2007;51:105-11.

    65. Feng MI, Huang S, Kaptein J, et al. Effect of sildenafil citrate on post-radical prostatectomy erectile dysfunction. J Urol 2000;164: 1935-8.

    66. Ferrini MG, Davila HH, Kovanecz I, Sanchez SP, Gonzalez-Cadavid NF, Rajfer J.Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology 2006; 68:429-35.

    67. Ficarra V, Novara G, Galfano A, Stringari C, Baldassarre R, Cavalleri S et al. Twelve-month selfreported quality of life after retropubic radical prostatectomy: a prospective study with Rand 36-Item Health Survey (Short Form-36). BJU Int 2006; 97: 274

    68. Fleischmann R, Iqbal I, Stern RL. Tacrolimus in rheumatoid arthritis. Expert Opin Pharmacother. 2006 Jan;7(l):91-8.

    69. Flynn RJ, Williams G. Long-term follow-up of patients with erectile dysfunction commenced on self injection with intracavernosal papaverine with or without phentolamine. Br J Urol 1996;78(4):628-31.

    70. Foley CL, Bott SRJ, Parkinson MC, et al. A large prostate at radicalretropubic prostatectomy does not adversely affect cancer control, continence or potency rates. BJU Int. 2003;92:370-374

    71. Fowler FJ Jr., Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE.Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988 —1990 (updated June 1993). Urology 1993; 42: 622.

    72. Fraiman MC, Lepor H, McCullough AR. Changes in penile morphometries in men with erectile dysfunction, after nerve-sparing radical retropubic prostatectomy. Mol Urol 1999; 3(2): 109-115

    73. Ganzer R, Blana A, Stolzenburg JU, Rabenalt R, Fritsche HM, Wieland WF, Denzinger S. Nerve quantification and computerized planimetry to evaluate periprostatic nerve distribution-does size matter? Urology. 2009 Aug;74(2):398-403. Epub 2009 Apr 18.

    74. Garcia FJ, Brock G. Current state of penile rehabilitation after radical prostatectomy. Curr Opin Urol. 2010 Mar 10. Epub ahead of print.

    75. Goeman L, Salomon L, La De Taille A, Vordos D, Hoznek A, Yiou R et al: Long-term functional and oncological results after retroperitoneal laparoscopic prostatectomy according to a prospective evaluation of 550 patients. World J Urol 2006; 24: 281.

    76. Gold BG, Katoh K, Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J Neurosci. 1995 Nov;15(l 1):7509-16.

    77. Gontero M. Galzerano, R. Bartoletti, et al. New insights into the pathogenesis of penile shortening after radical prostatectomy and the role of postoperative sexual function. The Journal of Urology, vol. 178, no. 2, pp. 602-607, 2007

    78. Gontero P, Fontana F, Bagnasacco A, et al. Is there an optimal time for intracavernous prostaglandin El rehabilitation following nonnerve sparing radical prostatectomy? Results from a hemodynamic prospective study. J Urol. 2003 Jun; 169(6): 2166-9.

    79. Gray RR, Keresteci AG, St Louis EL, Grosman H, Jewett MA, Rankin JT et al. Investigation of impotence by internal pudendal angiography: experience with 73 cases. Radiology 1982; 144: 773.

    80. Gupta R, Kirschen J, Barrow RC 2nd, Eid JF. Predictors of success and risk factors for attrition in the use of intracavernous injection. J Urol 1997; 157(5): 1681 -86.

    81. Gustafsson O., Theorell, T., Norming U. et al. Psychological reactions in men screened for prostate cancer. Br J Urol, 75: 631, 1995

    82. Hayashi N, Minor TX, Carrion R, Price R, Nunes L, Lue TF. The effect of FK1706 on erectile function following bilateral cavernous nerve crush injury in a rat model. J Urol. 2006 Aug;176(2):824-9.

    83. Hinh P., Run Wang. Overview of Contemporary Penile Rehabilitation Therapies Adv Urol. 2008; 2008: 481218. Published online 2008 September 4. doi: 10.1155/2008/481218. PMCID: PMC2531200

    84. Hollenbeck BK, Dunn RL, Wei JT, Montie JE, Sanda MG. Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument. J Urol. 2003 Apr;169(4):1453-7.

    85. Hong EK, Lepor H, McCullough AR. Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nerve-sparing radical retropubic prostatectomy (RRP). Int J Impot Res. 1999 Sep; 11 Suppl 1:S15-22.

    86. Hong SK, Han BK, Jeong SJ, Byun SS, Lee SE. Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy. J Urol. 2007 Aug; 178(2):613-6.

    87. Hsu EI, Hong EK, Lepor H. Influence of body weight and prostate volumeon intraoperative, perioperative, and postoperative outcomes after radical retropubic prostatectomy. Urology. 2003 Mar;61(3):601-6.

    88. Hsu KC, Orvieto MA, Mikhail AA, Gofrit ON, Lin S, Schaeffer AJ, Shalhav AL, Zagaja GP. Effect of prostate weight on operative and postoperative outcomes of robotic-assisted laparoscopic prostatectomy. Urology. 2007 Feb;69(2):300-5.

    89. Hu JC, Elkin EP, Pasta DJ, et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol 2004; 171(2 Pt 1): 703-707.

    90. Hu WL, Hu LQ, Li SW, Zheng XM, Tian BC Expression of transforming growth factor-beta 1 in penile tissue from rats with bilateral cavernosal nerve ablation. BJU Int. 2004 Aug;94(3):424-8.

    91. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005; 173(5): 1673-1676.

    92. Isbarn H, Pinthus JH, Marks LS, Montorsi F, Morales A, Morgentaler A, Schulman C. Testosterone and Prostate Cancer: Revisiting Old Paradigms. Eur Urol. 2009 Jul;56(l):48-56.

    93. Kaiho Y, Nakagawa H, Saito H, et al. Nerves at the Ventral Prostatic Capsule Contribute to Erectile Function: Initial Electrophysiological Assessment in Humans. Eur Urol 2009; 55: 148-155

    94. Kaminska B, Gaweda-Walerych K., Zawadzka M. Molecular mechanisms of neuroprotective action of immunosuppressants facts and hypotheses. J Cell Mol Med. 2004 Jan-Mar;8(l):45-58.

    95. Karakiewicz P, Shariat SF, Naderi A, Kadmon D, Slawin KM. Reliability of remembered International Index of Erectile Function domain scores in men with localised prostate cancer. Urology 2005; 65 : 131-5

    96. Karakiewicz PI, Tanguay S, Kattan MW, Elhilali MM, Aprikian AG. Erectile and urinary dysfunction after radical prostatectomy for prostate cancer in Quebec: a population-based study of 2415 men. Eur Urol 2004; 46: 188.

    97. Kattan S. Double-blind randomized crossover study comparing intracorporeal prostaglandin El with combination of prostaglandin El and lidocaine in the treatment of organic impotence. Urology 1995;45:1032-6.

    98. Katz D, Bennett NE, Stasi J, Eastham JA, Guillonneau BD, Scardino PT, Mulhall JP. Chronology of Erectile Function in Patients with Early Functional Erections Following Radical Prostatectomy. J Sex Med. 2009 Sep 30. Epub ahead of print.

    99. Katz DA, Jarrard DF, McHorney CA, Hillis SL, Wiebe DA, Fryback DG. Health perceptions in patients who undergo screening and workup for prostate cancer. Urology. 2007 Feb;69(2):215-20.

    100. Katz R, Salomon L, Hoznek A, de la Taille A, Vordos D, Cicco A et al. Patient reported sexual function following laparoscopic radical prostatectomy. J Urol 2002; 168: 2078.

    101. Kaul S, Savera A, Badani K, Fumo M, Bhandari A, Menon M. Functional outcomes and oncological efficacy of Vattikuti Institute prostatectomy with Veil of Aphrodite nerve-sparing: an analysis of 154 consecutive patients. BJU Int 2006; 97: 467.

    102. Kava BR. Advances in the management of post-radical prostatectomy erectile dysfunction: treatment strategies when PDE-5 inhibitors don't work. Rev Urol 2005;7(Suppl 2): S39-50 J Urol. 1997 Jun;157(6):2132-4.

    103. Khera M., Grober ED, Najari B, Colen JS, Mohamed O, Lamb DJ, Lipshultz LI. Testosterone replacement therapy following radical prostatectomy. J Sex Med. 2009 Apr;6(4):l 165-70.

    104. Kirschner-Hermanns R, Jakse G. Quality of life following radical prostatectomy. Crit Rev Oncol Hematol. 2002 Aug;43(2):141-51.

    105. KiyoshimaK,Yokomizo A,Yoshida T,Tomita K,Yonemasu H, Nakamura M, et al. Anatomical features of periprostatic tissue and its surroundings: a histological analysis of 79 radical retropubic prostatectomy specimens. Jpn J Clin Oncol 2004;34:463-8.

    106. Klein L.T., Miller MI, Buttyan R, Raffo AJ, Burchard M, Devris G,et al. Apoptosis in the rat penis after penile denervation. J Urol 1997;158:626-30.

    107. Koeman M, van Driel MF, Schultz WC, Mensink HJ. Orgasm after radical prostatectomy. Br J Urol. 1996 Jun;77(6):861-4.

    108. Korfage IJ, Essink-Bot ML, Borsboom GJ, Madalinska JB, Kirkels WJ, Habbema JD et al: Fiveyear follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer 2005; 116: 291.

    109. Kovanecz I, Rambhatla A, Ferrini M, et al. Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res 2008; 20: 202—12.

    110. Kovanecz I, Rambhatla A, Ferrini MG, et al. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int 2008;101:203-10.

    111. Kubler HR, Tseng TY, Sun L, Vieweg J, Harris MJ, Dahm P. Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal prostatectomy. J Urol 2007; 178: 488.

    112. Kundu SD, Roehl KA, Eggener SE, Antenor JA, Han M, Catalona WJ. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 2004; 172: 2227.

    113. Lagoda G, Jin L, Lehrfeld TJ, Liu T, Burnett AL. FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms. J Sex Med. 2007 Jul;4(4 Pt 1):908-16.

    114. Lakin MM, Montague DK, VanderBrug Medendorp S, et al. Intracavernous injection therapy: analysis of results and complications. J Urol 1990;143:1138-41.

    115. Laurikainen A, Hiltunen JO, Thomas-Crusells J, Vanhatalo S, Arumae U, Airaksinen MS, Klinge E, Saarma M. Neurturin is a neurotrophic factor for penile parasympathetic neurons in adult rat. J Neurobiol. 2000 May;43(2): 198-205.

    116. Le JD, Cooperberg MR, Sadetsky N, Hittelman AB, Meng MV, Cowan JE, Latini DM, Carroll PR. Changes in specific domains of sexual function and sexual bother after radical prostatectomy. BJU Int. 2010 Oct; 106(7): 1022-9

    117. Lee M, Doolabh VB, Mackinnon SE, Jost S. FK506 promotes functional recovery in crushed rat sciatic nerve. Muscle Nerve. 2000 Apr;23(4):633-40.

    118. Lehmann K, Casella R, Blochlinger A, Gasser TC. Reasons for discontinuing intracavernous injection therapy with prostaglandin El (alprostadil). Urology. 1999;53:397-400.

    119. Lepor H, McCullough A. Penile rehabilitation post-prostatectomy: Is there a role for MUSE? Rev Urol 2008;10:1-5.

    120. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, Abdel-Mageed AB, Hellstrom WJ. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl. 2003 Mar-Apr;24(2):239-45.

    121. Li X, Gonias SL, Campana WM. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury. Glia. 2005 Sep;51(4):254-65.

    122. Linet OI, Ogrinc FG. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.N Engl J

    123. Med. 1996 Apr 4;334(14):873-7.

    124. Liu T, Allaf ME, Lagoda G, Burnett AL. Erythropoietin receptor expression in the human urogenital tract: immunolocalization in the prostate, neurovascular bundle and penis. BJU Int. 2007 Nov; 100(5): 1103-6. Epub 2007 Sep 14.

    125. Mah K, Binik YM. The nature of human orgasm: a critical review of major trends.Clin Psychol Rev. 2001 Aug;21(6):823-56.

    126. Martínez-Salamanca García JI, Jara Rascón J, Moneada Iribarren I, Garcia Burgos J, Hernández Fernández C. Orgasm and its impact on quality of life after radical prostatectomy Actas Urol Esp. 2004 Nov-Dec;28(10):756-60.

    127. Matin SF: Recognition and preservation of accessory pudendal arteries during laparoscopic radical prostatectomy. Urology 2006; 67: 1012.

    128. McCullough A. Penile change following radical prostatectomy: size, smooth muscle atrophy, and curve. Curr Urol Rep. 2008; Nov.9(6):492-9.

    129. McCullough AR. Rehabilitation of erectile function following radical prostatectomy Asian J Androl 2008; 10(1): 61-74

    130. McGovern PM, Gross CR, Krueger RA, et al. False-positive cancer screens and health-related quality of life. Cancer Nurs 27: 347-352, 2004

    131. Menon M, Shrivastava A, Kaul S, Badani KK, Fumo M, Bhandari M, Peabody JO. Vattikuti Institute prostatectomy: contemporary technique and analysis of results. Eur Urol. 2007 Mar;51(3):648-57

    132. Menon M, Shrivastava A, Kaul S, Badani KK, Fumo M, Bhandari M, Peabody JO. Vattikuti Institute prostatectomy: contemporary technique and analysis of results. Eur Urol. 2007 Mar;51(3):648-57; discussion 657-8. Epub 2006 Nov 3.

    133. Menon M, Tewari A, Peabody J, et al. Vattikuti Institute prostatectomy: technique. J Urol 2003;169:2289-92.

    134. Meyer JP, Gillatt DA, Lockyer R, Macdonagh R The effect of erectile dysfunction on the quality of life of men after radical prostatectomy.BJU Int. 2003 Dec;92(9):929-31.

    135. Montorsi F, Briganti A, Salonia A, et al. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 2004;45:123-33

    136. Montorsi F, Brock G, Lee J, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nervesparing radical prostatectomy. Eur Urol 2008;54:924-31

    137. Moreland R.B. Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence. Int J Impot Res.- 1998; 10: 113-20.

    138. Morgentaler A. Testosterone therapy in men with prostate cancer: scientific and ethical considerations. J Urol. 2009 Mar;181(3):972-9.

    139. Moriel EZ, Rajfer J. Sodium bicarbonate alleviates penile pain induced by intracavernous injections forerectile dysfunction. J Urol 1993; 149(5 Pt 2):1299-300.

    140. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med. 2005 Jul;2(4):532-40; discussion 540-2.

    141. Mulhall JP, Gray don RJ. The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy. Int J Impot Res 1996; 8(2): 91-94.

    142. Mulhall JP, Levine LA, Junemann KP Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction. Urology. 2006 Sep;68(3 Suppl): 17-25.

    143. Mulhall JP, Secin FP, Guillonneau B. Artery sparing radical prostatectomy—myth or reality? J Urol. 2008 Mar; 179(3):827-31. Epub 2008 Jan 25. Review.

    144. Mulhall JP, Slovick R, Hotaling J, et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002; 167(3): 1371-1375.

    145. Mulhall JP. Defining and reporting erectile function outcomes after radical prostatectomy: challenges and misconceptions. J Urol. 2009 Feb;181(2):462-71. Epub 2008 Dec 13.

    146. Nandipati KC, Raina R, Agarwal A, Zippe CD. Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management.Drugs Aging. 2006;23(2):101-17.

    147. Nieschlag E., Behre H.M. (Eds.). Andrology 2nd Edition

    148. Noldus J, Michl U, Graefen M, Haese A, Hammerer P, Huland H: Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy. Eur Urol 2002; 42: 118.

    149. Parsons JK, Marschke P, Maples P, Walsh PC. Effect of methylprednisolone on return of sexual function after nerve-sparing radical retropubic prostatectomy. Urology. 2004 Nov;64(5):987-90.

    150. Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD et al. 5-Year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol 2005; 173: 1701

    151. Perez MA, Skinner EC, Meyerowitz BE. Sexuality and intimacy following radical prostatectomy: patient and partner perspectives. Health Psychol 2002; 21:288-93

    152. Polascik TJ and Walsh PC. Radical retropubic prostatectomy:the influence of accessory pudendal arteries on the recovery of sexual function. J Urol 1995; 154: 150.

    153. Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J Urol 2000; 164: 1929.

    154. Raina R, Lakin MM, Agarwal A, Mascha E, Montagne DK, Klein E, Zippe CD. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology 2004;63(5):960-6.

    155. Raina R, Lakin MM, Thukral M, et al. Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Int J Impot Res 2003;15:318-22

    156. Raina R, Pahlajani G, Agarwal A, et al. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity. BJU Int 2007; 100:131721.

    157. Rhoden EL, Averbeck MA, Teloken PE Androgen replacement in men undergoing treatment for prostate cancer. J Sex Med. 2008 Sep;5(9):2202-8.

    158. Rodriguez E Jr, Finley DS, Skarecky D, Ahlering TE. Single institution 2-year patient reported validated sexual function outcomes after nerve sparing robot assisted radical prostatectomy. J Urol. 2009 Jan;181(l):259-63. Epub 2008 Nov 14.

    159. Rogers CG, Trock BP and Walsh PC: Preservation of accessory pudendal arteries during radical retropubic prostatectomy: surgical technique and results. Urology 2004; 64: 148.

    160. Rosen MP, Greenfield AJ, Walker TG, Grant P, Guben JK, Dubrow J et al. Arteriogenic impotence: findings in 195 impotent men examined with selective internal pudendal angiography. Young Investigator's Award. Radiology 1990; 174: 1043.

    161. Rosen RC, Althof SE, Giuliano F. Research instruments for the diagnosis and treatment of patients with erectile dysfunction. Urology. 2006 Sep;68(3 Suppl):6-16.

    162. Rosen RC, Riley A, Wagner G. et al .The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822.

    163. Roumeguere T, Bollens R, Vanden Bossche M, et al. Radical prostatectomy: a prospective comparisonof oncological and functional results between open and laparoscopic approaches. World J Urol 2003;20: 360-6.

    164. Rozet F, Galiano M, Cathelineau X, Barret E,Cathala N, Vallancien G. Extraperitoneal laparoscopic radical prostatectomy: a prospective evaluation of 600 cases. J Urol 2005; 174: 908.

    165. Ruiz Rubio JL, Hernandez M, Rivera de los Arcos L, et al. Mechanisms of prostaglandin El-induced relaxation in penile resistance arteries. J Urol 2004;171:968-73.

    166. Safarinejad MR, Asgari MA, Hosseini SY, Lashay A, Amini E. Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil. Dadkhah F Int J Impot Res. 2009 Oct 29.

    167. Salonia A, Zanni G, Gallina A et «/.Baseline potency in candidates forbilateral nerve sparing radical retropubic prostatectomy. Eur Urol. 2006 Aug;50(2):360-5. Epub 2006 Jan 4.

    168. Saranchuk JW, Kattan MW, Elkin E, Touijer AK, Scardino PT, Eastham JA: Achieving optimal outcomes after radical prostatectomy. J Clin Oncol 2005; 23:4146.

    169. Savoie M, Kim SS, Soloway MS. A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. J Urol. 2003 Apr; 169(4): 1462-4.

    170. Schwartz EJ, Wong P, Gray don RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004; 171:7714.

    171. Secin FP, Karanikolas N, Touijer AK, Salamanca JI, Vickers A J and Guillonneau B. Anatomy of accessory pudendalarteries in laparoscopic radical prostatectomy. J Urol 2005; 174: 523.

    172. Shikanov S, Desai V, Razmaria A, Zagaja GP, Shalhav AL. Robotic Radical Prostatectomy for Elderly Patients: Probability of Achieving Continence and Potency 1 Year After Surgery. J Urol. 2010 Mar 16. Epub ahead of print.

    173. Shimizu T, Hisasue S, Sato Y, Kato R, Kobayashi K, Tsukamoto T. Erectile dysfunction following nerve-sparing radical retropubic prostatectomy and its treatment with sildenafil. Int J Urol 2005; 12: 552.

    174. Shindel A, Quayle S, Yan Y, Husain A, Naughton C. Sexual dysfunction in female partners of men who have undergone radical prostatectomy correlates with sexual dysfunction of the male partner. J Sex Med. 2005 Nov;2(6):833-41;

    175. Sidi AA, Becher EF, Zhang G, et al. Patient acceptance of and satisfaction with an external negative pressure device for impotence. J Urol. 1990 Nov; 144(5): 1154-6.

    176. Sievert KD, Hennenlotter J, Laible I, Amend B, Schilling D, Anastasiadis A, Kuehs U, Nagele U, Stenzl A. The periprostatic autonomicnerves-bundle or layer? Eur Urol. 2008 Nov;54(5): 1109-16. Epub 2008 Jun 13.

    177. Song YS, Lee HJ, Park IH, Kim WK, Ku JH, Kim SU. Potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells. Int J Impot Res. 2007 Jul-Aug; 19(4):378-85.

    178. Song YS, Lee HJ, Park IH, Lim IS, Ku JH, Kim SU. Human neural crest stem cells transplanted in rat penile corpus cavernosum to repair erectile dysfunction. BJU Int. 2008 Jul;102(2):220-4; discussion 224.

    179. Srougi M. Early pelvic-floor biofeedback training promotes improvement of erectile function after radical prostatectomy. J Urol. 2009Apr; 181(4), Supplement 524-525.

    180. Stanford JL, Feng Z, Hamilton AS, Gilliland FD,Stephenson RA, Eley JW et al: Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000; 283:354

    181. Stolzenburg J-U, Robert Rabenalt , Minh Do et. al. Intrafascial NerveSparing Endoscopic Extraperitoneal Radical Prostatectomy. Eur Urol 2008; 53:931-940

    182. Stolzenburg J-U, Schwalenberg T, Horn L-C, et. al. Anatomical landmarks of radical prostatectomy./ Eur Urol 2007; 51: 629-39.

    183. Sundaram CP, Thomas W, Pry or LE, Sidi AA, Billups K, Pry or JL. Long-term follow-up of patients receiving injection therapy for erectile dysfunction. Urology 1997;49(6):932-35.

    184. Tal R, Alphs HH, Krebs P, Nelson CJ, Mulhall JP. Erectile function recovery rate after radical prostatectomy: a meta-analysis. J Sex Med. 2009 Sep;6(9):2538-46. Epub 2009 Jun 9.

    185. Tariq AI Shaiji, MD ChB; Trustin Domes, MD; Gerald Brock, MD. Penile rehabilitation following treatment for prostate cancer: an analysis of thecurrent state of the art. Can Urol Assoc J. 2009 Feb;3(l):37-48.

    186. Tewari A, Takenaka A, Mtui E, Horninger W, Peschel R,

    187. Bartsch G, et al. The proximal neurovascular plate and the tri-zonal neural architecture around the prostate gland: importance in the athermal robotic technique of nervesparing prostatectomy. BJU Int 2006;98:314-23.

    188. Touijer K, Eastham JA, Secin FP, et al. Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005. J Urol 2008;179:1811-7.

    189. Turns D. Psychosocial issues: pelvic exenterative surgery. J Surg Oncol. 2001 Mar;76(3):224-36.

    190. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol. 2003 Mar; 169(3): 11759.

    191. Valentine H, Chen Y, Guo H, McCormick J, Wu Y, Sezen SF, Hoke A, Burnett AL, Steiner JP. Neuroimmunophilin ligands protect cavernous nerves after crush injury in the rat: new experimental paradigms. Eur Urol. 2007 Jun;51(6): 1724-31. Epub 2006 Nov 16.

    192. Van Kampen M, De Weerdt W, Claes H, Feys H, De Maeyer M, Van Poppel H. Treatment of erectile dysfunction by perineal exercise, electromyographic biofeedback, and electrical stimulation. Phys Ther. 2003 Jun;83(6):536-43.

    193. Vardi Y, Sprecher E, Gruenwald I. Logistic regression and survival analysis of 450 impotent patients treated with injection therapy: long-term dropout parameters. J Urol 2000;163(2):467-70.

    194. Visser MR, van Lanschot JJ, van der Velden J, Koek JJ, Gouma DJ, Spangers MA. Quality of life in newly diagnosed cancer patients waiting for surgery is seriously impaired. / Surg Oncol 2006; 93 : 571—7

    195. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol. 1982; 128: 492-497.

    196. Walsh PC, Marschke P, Ricker D, Burnett A/L. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000; 55: 58-61.

    197. Walsh PC. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol 1998; 160:2418-24.

    198. Zippe CD, Pahlajani G. Vacuum erection devices to treat erectile dysfunction and early penile rehabilitation following radical prostatectomy. Curr Urol Rep. 2008 Nov; 9(6):506-13.

    199. Zisman A, Leibovici D, Kleinmann J, Siegel YI, Lindner A. The impact of prostate biopsy on patient well-being: a prospective study of pain, anxiety and erectile dysfunction. J Urol. 2001 Feb;165(2):445-54.

    200. Zorn KC, Orvieto MA, Mikhail AA, Gofrit ON, Lin S, Schaeffer AJ, Shalhav AL, Zagaja GP. Effect of prostate weight on operative and postoperative outcomes of robotic-assisted laparoscopic prostatectomy. Urology. 2007 Feb; 69(2):300-5.

    201. Zumbe J, Porst H, Sommer F, et al. Comparable efficacy of once-daily versus on-demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE study. Eur Urol 2008;54:204-10.

    Источник: http://medical-diss.com/medicina/seksualnaya-funkt...

О сайте

1avtoportal.ru